NASDAQ:CARA - Cara Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$16.54 -0.36 (-2.13 %)
(As of 02/20/2019 04:00 PM ET)
Previous Close$16.90
Today's Range$16.28 - $16.91
52-Week Range$11.46 - $24.30
Volume527,710 shs
Average Volume619,049 shs
Market Capitalization$649.86 million
P/E Ratio-8.89
Dividend YieldN/A
Beta2.87

Analyst Ratings

Cara Therapeutics (NASDAQ:CARA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
11 Wall Street analysts have issued ratings and price targets for Cara Therapeutics in the last 12 months. Their average twelve-month price target is $24.7360, suggesting that the stock has a possible upside of 49.55%. The high price target for CARA is $30.00 and the low price target for CARA is $13.36. There are currently 1 hold rating and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.912.913.002.80
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $24.7360$25.5360$26.1111$25.8636
Price Target Upside: 49.55% upside68.78% upside32.41% upside40.41% upside

Cara Therapeutics (NASDAQ:CARA) Consensus Price Target History

Price Target History for Cara Therapeutics (NASDAQ:CARA)

Cara Therapeutics (NASDAQ:CARA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/6/2019Jefferies Financial GroupInitiated CoverageBuy$22.00LowView Rating Details
1/15/2019Bank of AmericaInitiated CoverageNeutral$19.00LowView Rating Details
12/20/2018HC WainwrightSet Price TargetBuy$30.00LowView Rating Details
12/20/2018LaidlawSet Price TargetBuy$30.00LowView Rating Details
12/20/2018Canaccord GenuitySet Price TargetBuy$25.00LowView Rating Details
12/20/2018Piper Jaffray CompaniesSet Price TargetBuy$27.00LowView Rating Details
12/20/2018Janney Montgomery ScottInitiated CoverageBuy$27.00 ➝ $13.36HighView Rating Details
11/7/2018Cantor FitzgeraldSet Price TargetBuy$27.00HighView Rating Details
8/8/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$22.00 ➝ $26.00HighView Rating Details
6/27/2018Needham & Company LLCBoost Price TargetPositive ➝ Buy$23.00 ➝ $28.00HighView Rating Details
3/16/2018Seaport Global SecuritiesReiterated RatingBuyLowView Rating Details
11/7/2017Raymond JamesBoost Price TargetMarket Perform$25.00 ➝ $26.00N/AView Rating Details
11/7/2017CIBCLower Price Target$26.00 ➝ $24.00N/AView Rating Details
11/7/2017BMO Capital MarketsReiterated RatingMarket Perform$25.00N/AView Rating Details
10/17/2017ScotiabankBoost Price TargetOutperform$31.00 ➝ $31.50N/AView Rating Details
8/3/2017Royal Bank of CanadaLower Price TargetOutperform$31.00 ➝ $29.00LowView Rating Details
(Data available from 2/20/2017 forward)
This page was last updated on 2/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel